"Revolutionary Cancer Treatment Developed by Houston Oncologist"
Houston oncologist Philip Salem has developed a groundbreaking cancer treatment called ICTriplex, which combines immunotherapy, chemotherapy, and targeted therapy and has achieved a 50% complete remission rate in patients. Published in the American Society of Clinical Oncology Journal, Salem's research on ICTriplex showed a 90% remission rate across multiple advanced cancer types, with lung and pancreatic cancer patients experiencing a 70% complete remission rate. Patients from around the world have traveled to Salem's oncology center in Houston for this innovative treatment, expressing gratitude and hope for the future.